contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


braincool-ab-publ-cancels-the-loan-agreement-with-eib-as-it-is-no-longer-appropriate-for-the-company

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

BrainCool operates in the medical technology sector. The company develops products for medical cooling of the brain. The technology is developed as cooling pads that are applied to different parts of the patient's body, where the system controls body temperature. The products are used in the treatment of various serious conditions including stroke, cardiac arrest, as well as concussion and migraine. BrainCool was founded in 2010 and is headquartered in Lund.

BrainCool

BrainCool AB (publ) refrains from utilizing the loan package of EUR 12.5 million that The European Investment Bank (EIB) granted the company in December 2023. BrainCool has deemed that the relatively...

<div class="mfn-body"><p>BrainCool AB (publ) refrains from utilizing the loan package of EUR 12.5 million that The European Investment Bank (EIB) granted the company in December 2023. BrainCool has deemed that the relatively large loan package is no longer wholly appropriate for the company.<br>&nbsp;<br><strong>Jon Berg, CEO of BrainCool, comments:</strong><br>- “BrainCool’s current cash position is strong considering its successful right issue in May 2024 which contributed SEK 85.8 million (before costs) in new capital to the company. Utilizing even just the first tranche of the EIB loan facility would result in a loan of EUR 6 million, a cash contribution which is not deemed to be required at present.”<br>&nbsp;<br>BrainCool´s sales are increasing, and the production cost reduction program is proceeding according to plan. Furthermore, BrainCool is in the process of gradually focusing its operations on its core business, which implies that some projects that were tied to the EIB financing will not be carried out. In combination, this results in lower capital requirements for BrainCool compared to when the EIB facility was agreed.<br>&nbsp;<br>The EIB loan package was divided into two tranches of EUR 6 million and EUR 6.5 million respectively. The first tranche was due to be drawn in September 2024, and the second tranche stipulated that the first tranche had been drawn. Therefore, BrainCool needs to cancel the entire loan package in one and at the same time. The EIB loan package also implied a future dilution of shares in BrainCool via warrants. Since the EIB loan is now cancelled, there will be no such dilution.<br>&nbsp;<br><strong>Lotta Valfridsson, CFO of BrainCool, comments:</strong><br>- “The due diligence process of being approved by the EIB for the loan facility was comprehensive and fairly resource consuming for the company during 2023. At the same time, it has given BrainCool a quality grade that will remain with the company, despite us not utilizing the facility.”<br>&nbsp;<br>BrainCool would like to thank The European Investment Bank for the cooperation.</p></div><div class="mfn-footer mfn-46d5b376c4f5"><p><strong class="mfn-heading-1">Contact</strong><br><strong>For more information</strong><br>Jon Berg - CEO<br>+46 722 50 91 19<br>E-mail: jon.berg@braincool.se</p></div><div class="mfn-footer mfn-about mfn-65972121fba8"><p><strong class="mfn-heading-1">About Us</strong><br>BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.<br>Eminova Fondkommission AB is the company’s Certified Adviser.</p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar"><p><em>This information is information that BrainCool is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-09-23 08:39 CEST.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-image"><p><strong class="mfn-heading-1">Image Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/5fddc655-ddd1-4d5d-a2fd-dd32756aea8a/den-europeiska-unionen.jpeg">Den Europeiska Unionen</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/f18eba71-d7e9-4468-b00a-093c4cc57303/braincool-ab-publ-cancels-the-loan-agreement-with-eib-as-it-is-no-longer-appropriate-for-the-company.pdf" class="mfn-generated mfn-primary">BrainCool AB (publ) cancels the loan agreement with EIB, as it is no longer appropriate for the company</a></p></div>

BrainCool AB (publ) cancels the loan agreement with EIB, as it is no longer appropriate for the company